The FDA recently authorized the usage of a historic COVID vaccine by Moderna and Pfizer. The booster, known as a ‘bivalent’ vaccine, is targeted specifically toward the two versions of the Omicron strain of the Coronavirus. Although demand for previous boosters was high when the vaccine was relatively new, opinions have begun to differ on.